261 results on '"Yoon, Donghoon"'
Search Results
2. Figure S4 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
3. Supplemental methods from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
4. Data from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
5. Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
6. Supplementary Data - Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
7. Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma
8. Visualizing collagen proteolysis by peptide hybridization: From 3D cell culture to in vivo imaging
9. Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo
10. Abstract 3828: Herbal extracts from lycii radicis corex and achyranthes japonica prevent multiple myeloma progression
11. Experimental Validation of Diffraction Lithography for Fabrication of Solid Microneedles
12. Abstract 1655: Development of humanized diffuse large B-cell lymphoma mouse models
13. The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression.
14. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor
15. HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis
16. Herbal Extracts from Lycii Radicis Corex and Achyranthes japonica Prevent Multiple Myeloma
17. Development of Humanized Diffuse Large B-Cell Lymphoma Mouse Models
18. An Improved Animal Model of Multiple Myeloma Bone Disease
19. Animal Models of Multiple Myeloma Bone Disease
20. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation
21. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism
22. Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathway
23. Cre recombinase expression controlled by the hematopoietic regulatory domain of Gata-1 is erythroid-specific
24. Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1α and HIF-2α
25. Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions
26. Electoretinographic Findings in Knockin Mice with Gain of Function and Loss of Function Erythropoietin Receptor Signaling: Poster No.: VR-D1-353 Panel No.: 353
27. Liquid biopsy and its role in an advanced clinical trial for lung cancer
28. Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice
29. Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma
30. Daratumumab Single Agent and Daratumumab Plus Pomalidomide and Dexametasone in Relapsed/Refractory Multiple Myeloma: A Real Life Retrospective Evaluation
31. Rigosertib, a Pan RAS Inhibitor, Decreases Mouse and Human Myeloma Cell Growth in Preclinical Models
32. Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors
33. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor
34. Thymus-Derived PTH (TPTH) Is Increased after Thyroparathyroidectomy in C57BL6/Kalwrij Mice and Modulates Mouse Sensitivity to 5TGM1 Myeloma Cell Line
35. Polycythemia of Mice with Human Gain-of-Function EPOR (mtHEPOR) Is Transiently Corrected in Perinatal Life in Association with Low Epo and Increased Erythrocyte Phosphatidylserine Exposure
36. Higher Expressions of PTH Receptor Type 1 and/or 2 in Bone Marrow Is Associated to Longer Survival in Newly Diagnosed Myeloma Patients Enrolled in Total Therapy 3
37. Surgical Control/Cure of 5TGM1 Murine Multiple Myeloma Model By Thyroparathyroidectomy
38. Waldenstrom's Macroglobulinemia Associated Bone Disease the UAMS Experience
39. Neocytolysis Is Mediated by down Regulation of Catalase By Mir-21 Resulting in defective Clearance of reticulocyte mitochondrial ROS
40. Molecular Basis of Neocytolysis.
41. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism
42. Tissue-Specific HIF-1 and HIF-2 Regulatory Elements and Their Roles in Erythropoietin Gene Expression
43. Neocytolysis Is Associated with Changes in Increase of Mitochondrial Content and Impaired Protection From Reactive Oxygen Species
44. Hypoxia. 5. Hypoxia and hematopoiesis
45. Study of Two Subjects with Absence of Severe Anemia with Homozygous β0 Thalassemia Due to Disrupted γ-to-β Switch
46. MicroRNA-101 Is Down-Regulated In PV and ET Granulocytes and Its Decrease Is Associated with Over-Expression of Histone Methyltransferase In EZH2 In MPN Patients
47. Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathway
48. EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors
49. miR-451enhances erythroid differentiation in K562 cells
50. Increased Ratios of Internal Organ Volume to Body Mass in Chuvash Polycythemia and HIF-2α Repression of p21Cip Expression through C-MYC.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.